There is an enormous increase in the application of 3D bioprinting technology in various medical and healthcare sectors over the worldwide market. Currently, bioprinting can be used to print various tissues and organs. 3D Bioprinting has varies applications like, the 3D printer has advanced capacity to print skin tissue, heart tissue, and veins among other fundamental tissues that could be suitable for surgical therapy and transplantation procedures. The advancements in 3D printing technology have increased due to the growing demand for tissue and organ transplants, driving the worldwide market for 3D bioprinting significantly.
In today’s competitive world of technology, 3D bioprinting has gained a lot of global market and advancement in medical field. According to the several reports and, the global market for 3D bioprinting is widely spread across Asia Pacific, North America, Europe, and the other parts of the World.
The major market players in 3D Bioprinting includes several companies like Organovo – famous with the first 3D printable liver tissue, 3D Systems Inc., regenHU, 3D Biotek, Cyfuse Biomedical, BioBots, Aspect Biosystems, Rokit, 3D Bioprinting Solutions, Envision TEC, Stratasys Ltd., etc.